Position in INSM
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$499,998,043
+$157,338,175 QoQ
Shares Held
3,057,718
+55.3% QoQ
Ownership
1.41%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 93.30517071881711.ToString("F0")%
None 6.694829281182896.ToString("F0")%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Derivatives in INSM
reported options exposure · as of Sep 30, 2025CallValue
$0
CallShares
0
PutValue
$2,836,997
PutShares
19,700
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026AMERIPRISE FINANCIAL INC holds $4,230,069,783 across 189 Biotechnology names. INSM ranks #2 (11.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,633,481 | $1,175,954,602 | |
| 2 | INSM |
INSMED Inc
This page
|
3,057,718 | $499,998,043 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,608,476 | $304,082,386 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
319,677 | $246,995,233 | |
| 5 | ARGX |
Argenx SE
|
215,910 | $157,668,275 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,579,793 | $153,634,868 | |
| 7 | ASND |
Ascendis Pharma A/S
|
476,466 | $108,982,067 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,248,521 | $92,715,166 |
All Filings in INSM
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $499,998,043 | 3,057,718 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $342,659,868 | 1,968,857 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $391,977,791 | 2,721,879 | Shares | Defined | 2025-11-14 | |
| 2025-09-30 | $2,836,997 | 19,700 | Put | Defined | 2025-11-14 | |
| 2025-06-30 | $297,690,398 | 2,957,973 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $225,179,238 | 2,951,622 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $1,995,256 | 28,900 | Put | Defined | 2025-02-14 | |
| 2024-12-31 | $196,770,694 | 2,850,097 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $188,370,587 | 2,580,419 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $169,576,598 | 2,530,994 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $74,209,717 | 2,735,338 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $70,734,392 | 2,282,491 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $47,387,002 | 1,876,713 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $39,229,204 | 1,859,204 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $34,183,833 | 2,004,917 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $59,946,012 | 3,000,301 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $62,599,674 | 2,906,206 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $53,425,027 | 2,709,180 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $81,879,380 | 3,484,229 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $113,275,411 | 4,158,422 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $114,832,211 | 4,169,652 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $115,683,379 | 4,064,771 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $115,184,684 | 3,381,817 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $97,925,761 | 2,941,597 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $75,773,324 | 2,357,602 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $69,692,997 | 2,530,610 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $32,717,179 | 2,040,997 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||